Technology offers
The OTT-SSPA offers the access service to all the technologies developed by the Andalusian Public Healthcare System, including patents, utility models, know-how and software. This space features all the technologies available in our Catalogue of Technology Offers We include over 50 new offers every year. If you cannot find what you are looking for, you can contact us here.
STREPTOMYCES MUTANTS WITH HIGH GENETIC VARIABILITY
A research team of the Andalusian Public Health System, in collaboration with the University of Seville, CSIC and the University of Sussex, has developed an innovative method for the production of hypermutable actinobacteria.
HYPERMUTABLE STRAINS OF MYCOBACTERIUM TUBERCULOSIS AND M. SMEGMATIS
A research group of the Andalusian Public Health System, in collaboration with the University of Seville, CSIC and the University of Sussex, has developed hypermutable strains of M. tuberculosis and M. smegmatis.
METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS (IPSC)
A research group from Andalusian Public Health System has developed a method for inducing a somatic cell to acquire a less differentiated phenotype and for generating Induced Pluripotent Stem Cells (iPSC)
INSULATOR TO PREVENT SILENCING AND PROMOTE EXPRESSION IN STEM CELLS
A research group from Andalusian Public Health System (APHS) has developed a new insulator that improves the expression pattern of vectors.
TREATMENT OF NK CELL-MEDIATED DISEASES AND IFN-Γ MEDIATED DISEASES
A research group from Andalusian Public Health System has developed a composition capable of modulating the biological activity of NK cells and IFN-γ
GENE THERAPY FOR TREATMENT OF THE RETINOSIS PIGMENTOSA
A research group from APHS in collaboration with researchers of SCU and from CSIC has developed a non-viral transfection system for the treatment of Retinosis Pigmentosa.
BIOMARKERS FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS)
A research group from the Andalusian Public Health System (SSPA) has developed a kit for the diagnosis, prognosis and / or monitoring of Amyotrophic Lateral Sclerosis (ALS).
KIT FOR PREDICTING THE RESPONSE TO TREATMENT WITH MSCS IN PATIENTS WITH INFLAMMATORY DISEASES
A research group from Andalusian Public Health System has developed a kit for predicting the response to treatment with Mesenchymal Stem Cells (MSCs) in patients with inflammatory diseases.
USE OF NESTIN+ CELLS FOR DIFFERENTIATION TO MESODERM-DERIVED CELLS AND THE MAINTENANCE OF HAEMATOPOIESIS POYESIS
A research group of the Andalusian Public Health System has managed to demonstrate that Nestin+ cells can behave like mesenchymal stem cells. Which are capable of differentiating to osteocytes.
METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF VASCULAR PARKINSONISM AND PARKINSON'S DISEASE
A research group of the Andalusian Public Health System (SSPA) has developed a computer-implemented method for the differential diagnosis of vascular parkinsonism (VP) and Parkinson's disease (PD) as a clinical decision support tool.